200
Participants
Start Date
May 28, 2019
Primary Completion Date
January 31, 2020
Study Completion Date
March 31, 2020
Protocol for Management of Muscle Relaxation With Rocuronium Using Objective Monitoring and Reversal With Neostigmine or Sugammadex
The protocol includes specified appropriate rocuronium dosing and a valid pre-reversal assessment of the adductor pollicis response guides optimal neostigmine vs. sugammadex reversal.
Harborview Medical Center, Seattle
University of Washington
OTHER